首页> 外文期刊>Clinical neurology and neurosurgery >Preoperative localization of intracranial lesions with MRI using marking pills.
【24h】

Preoperative localization of intracranial lesions with MRI using marking pills.

机译:术前使用标记药进行MRI颅内病变的定位。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To describe a simple technique for preoperative surface localization of intracranial lesions. METHODS: 11 pills in total, including Alfarol (alfacalcidol) capsules, were affixed to a phantom with adhesive tape and a MRI scan was performed. The visibility of the pills and any spatial errors in determining their locations were evaluated. Between June 2006 and April 2009, we employed Alfarol capsules as a skin marker in MRI in clinical surgical cases. RESULTS: Alfarol capsules, whose actual size is 5.6 mm in diameter, were identified as a hyperintense spot at a size of 4.2, 4.2, and 4.5mm in diameter in T1-weighted, T2-weighted, and FLAIR (fluid attenuated inversion recovery) sequence images, respectively. The size discrepancies were within 1.4 mm. The average spatial errors were 0.7, 0.6, and 0.7 mm in T1-weighted, T2-weighted, and FLAIR sequence images, respectively. Other pills were not identified in the MRI scans. During this 35-month period, 8 patients underwent preoperative MRI-guided localization at our institution. There were 5 men and 3 women in whom 8 biopsies were performed. In all cases, the result of the biopsy was positive and useful for the treatment that followed. No perioperative complications were encountered. CONCLUSION: Alfarol capsule can be used as an external skin marker. Our simple and inexpensive method is a useful addition to preoperative evaluation of superficial intracranial lesions.
机译:目的:描述术前颅内病变表面定位的简单技术。方法:用胶带将总共11片药(包括Alfarol(alfacalcidol)胶囊)粘贴到体模上,并进行MRI扫描。评估药丸的可见性以及确定药丸位置时的空间误差。在2006年6月至2009年4月之间,我们在临床外科病例中将Alfarol胶囊用作MRI的皮肤标记。结果:实际直径为5.6 mm的Alfarol胶囊在T1加权,T2加权和FLAIR(流体衰减反转恢复)中被鉴定为直径分别为4.2、4.2和4.5mm的高强度斑点。序列图像。尺寸差异在1.4毫米以内。在T1加权,T2加权和FLAIR序列图像中,平均空间误差分别为0.7、0.6和0.7 mm。 MRI扫描未发现其他药丸。在这35个月的时间里,有8例患者在我们机构接受了MRI指导的术前定位。有5名男性和3名女性进行了8次活检。在所有情况下,活检的结果均为阳性,可用于随后的治疗。没有围手术期并发症发生。结论:阿尔法洛尔胶囊可作为皮肤外部标志物。我们的简单而廉价的方法是对术前评估颅内浅表病变的有用补充。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号